Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Gains from Investment Securities (2016 - 2022)

Bio Key International's Gains from Investment Securities history spans 10 years, with the latest figure at $55989.0 for Q2 2020.

  • For Q2 2020, Gains from Investment Securities changed N/A year-over-year to $55989.0; the TTM value through Dec 2022 reached $55989.0, down 42.27%, while the annual FY2022 figure was $105893.0, 5.89% up from the prior year.
  • Gains from Investment Securities for Q2 2020 was $55989.0 at Bio Key International, up from $40995.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.2 million in Q4 2017 and bottomed at $40995.0 in Q1 2020.
  • The 4-year median for Gains from Investment Securities is $200000.0 (2016), against an average of $315049.9.
  • The largest annual shift saw Gains from Investment Securities plummeted 83.02% in 2016 before it surged 399.1% in 2017.
  • A 4-year view of Gains from Investment Securities shows it stood at $247280.0 in 2016, then surged by 399.1% to $1.2 million in 2017, then tumbled by 71.49% to $351918.0 in 2018, then plummeted by 84.09% to $55989.0 in 2020.
  • Per Business Quant, the three most recent readings for BKYI's Gains from Investment Securities are $55989.0 (Q2 2020), $40995.0 (Q1 2020), and $351918.0 (Q4 2018).